Evidence map›Paper›PMID 27220334›Full record

ArticleNeurochemical research2016

Caspase-3-Dependent Proteolytic Cleavage of Tau Causes Neurofibrillary Tangles and Results in Cognitive Impairment During Normal Aging.

John C Means, Bryan C Gerdes, Simon Kaja, Nathalie Sumien, Andrew J Payne, Danny A Stark, Priscilla K Borden, Jeffrey L Price, Peter Koulen

Abstract read
In one paragraph

Article in Neurochemical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. In Vitro Antiviral Effect and Potential Neuroprotection ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
  12. Aggregation of Disordered Proteins Associated with Neurodegeneration.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

John C MeansDepartment of Ophthalmology, Vision Research Center, School of Medicine, University of Missouri-Kansas City, 2411 Holmes St., Kansas City, MO, 64108, USA.
Bryan C GerdesDepartment of Ophthalmology, Vision Research Center, School of Medicine, University of Missouri-Kansas City, 2411 Holmes St., Kansas City, MO, 64108, USA.
Simon KajaDepartment of Ophthalmology, Vision Research Center, School of Medicine, University of Missouri-Kansas City, 2411 Holmes St., Kansas City, MO, 64108, USA.
Nathalie SumienCenter for Neuroscience Discovery, Institute for Healthy Aging, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, TX, 76107, USA.
Andrew J PayneDepartment of Ophthalmology, Vision Research Center, School of Medicine, University of Missouri-Kansas City, 2411 Holmes St., Kansas City, MO, 64108, USA.
Danny A StarkDepartment of Ophthalmology, Vision Research Center, School of Medicine, University of Missouri-Kansas City, 2411 Holmes St., Kansas City, MO, 64108, USA.
Priscilla K BordenDepartment of Ophthalmology, Vision Research Center, School of Medicine, University of Missouri-Kansas City, 2411 Holmes St., Kansas City, MO, 64108, USA.
Jeffrey L PriceDepartment of Neurology and Cognitive Neuroscience, School of Medicine, University of Missouri-Kansas City, 2411 Holmes St., Kansas City, MO, 64108, USA.
Peter KoulenDepartment of Ophthalmology, Vision Research Center, School of Medicine, University of Missouri-Kansas City, 2411 Holmes St., Kansas City, MO, 64108, USA. koulenp@umkc.edu.
University of Missouri–Kansas City · USUniversity of North Texas Health Science Center · US

Funding

Protein Targets of Oxidative Brain AgingP01AG022550 · NIA · WEST VIRGINIA UNIVERSITY · PI SIMPKINS, JAMES W. · 2003 to 2013
$15.7M
System Gene Delivery for Alzheimer's Disease- SupplementP01AG010485 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI ZOLOTUKHIN, SERGEI · 1991 to 2009
$11.3M
ROLE OF MITHOCHONDRIAL ERB IN NEURONAL VULNDERABILITY TO NEUROTOXIC STRESSP01AG027956 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI SINGH, MEHARVAN · 2007 to 2017
$11.3M
Novel mechanism of action as therapeutic strategy for optic neuritisR01EY022774 · NEI · UNIVERSITY OF MISSOURI KANSAS CITY · PI KOULEN, PETER · 2012 to 2014
$1.2M
Confocal Laser Scanning MicroscopeS10RR027093 · NCRR · UNIVERSITY OF MISSOURI KANSAS CITY · PI KOULEN, PETER · 2010 to 2010
$497k
CONFOCAL MICROSCOPE FOR CAMPUS EXPANSION IN THE CBH BUILDING: NEUROSCIENCES10RR022570 · NCRR · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI KOULEN, PETER · 2006 to 2006
$356k
NCRR NIH HHS S10 RR022570NCRR NIH HHS S10 RR027093NEI NIH HHS R01 EY022774NIA NIH HHS P01 AG010485NIA NIH HHS P01 AG022550NIA NIH HHS P01 AG027956
6 · The paper itself

Abstract

Mouse models of neurodegenerative diseases such as Alzheimer's disease (AD) are important for understanding how pathological signaling cascades change neural circuitry and with time interrupt cognitive function. Here, we introduce a non-genetic preclinical model for aging and show that it exhibits cleaved tau protein, active caspases and neurofibrillary tangles, hallmarks of AD, causing behavioral deficits measuring cognitive impairment. To our knowledge this is the first report of a non-transgenic, non-interventional mouse model displaying structural, functional and molecular aging deficits associated with AD and other tauopathies in humans with potentially high impact on both new basic research into pathogenic mechanisms and new translational research efforts. Tau aggregation is a hallmark of tauopathies, including AD. Recent studies have indicated that cleavage of tau plays an important role in both tau aggregation and disease. In this study we use wild type mice as a model for normal aging and resulting age-related cognitive impairment. We provide evidence that aged mice have increased levels of activated caspases, which significantly correlates with increased levels of truncated tau and formation of neurofibrillary tangles. In addition, cognitive decline was significantly correlated with increased levels of caspase activity and tau truncated by caspase-3. Experimentally induced inhibition of caspases prevented this proteolytic cleavage of tau and the associated formation of neurofibrillary tangles. Our study shows the strength of using a non-transgenic model to study structure, function and molecular mechanisms in aging and age related diseases of the brain.

Indexed as

AgingAlzheimer DiseaseAnimalsBrainCaspase 3CognitionCognitive DysfunctionDisease Models, AnimalMaleMemory DisordersMice, Inbred C57BLMice, TransgenicNeurofibrillary Tanglestau ProteinsCasp3 protein, mouseCaspase 3tau ProteinsAge-related cognitive declineMolecular mechanisms in brain agingNeurofibrillary tanglesPreclinicalTauopathy

Identifiers

PMID27220334
PMCPMC4965284
OpenAlexW2395424197

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.